403. The Opioid Tragedy, Part 2: “It’s Not a ...

Podcasting started as a niche-nerd pursuit. Now it’s a $9 billion industry. Is that a lot? The strange economics of this thing we do. SOURCES:Jim Bankoff, chairman and C.E.O. of Vox Media.Ben Davis, head of digital at WME.Will Page, former chief economist at Spotify and author of ...  Show more

An economist calls America’s beef industry a “miracle.” An antitrust scholar calls it “broken.” Maybe they’re both right? SOURCES:Austin Frerick, agriculture antitrust expert, fellow at Yale University, author of Barons: Money, Power, and the Corruption of America's Food Industry ...  Show more

There have been drastic changes made in the regulation of opioids for medical treatment in the past few decades. However, with advent of fentanyl and carfentanil addiction, overdose-related death continues to increase. In this episode, our guests discuss continued regulation of o ...  Show more

Each year, the horrors of addiction claim thousands of lives -- but what if some substances can break the cycle of drug abuse? Join Ben and Matt to learn more about hallucinogens and addiction.

In 1960, FDA scientist Frances Oldham Kelsey is tasked with approving an application for a mild sedative to be sold in America. The drug is popular across Europe and is touted to be free of side effects, so this should be a routine job. But something doesn't sit right with France ...  Show more

Sam Harris speaks with Sally Satel about addiction. They discuss whether addiction should be considered a disease, the opiate epidemic in the U.S., the unique danger of fentanyl, the politicization of medicine, PTSD, and other topics. If the Making Sense podcast logo in your play ...  Show more